PolyMedix, Inc.(fka PYMXQ)

[WiseTrader55]

My best guess is that they have found new investors and this was one of the prerequisites to the deal. Nic has been the main problem from the beginning.

Many wonder why anyone would step in now. Think about it....timing is everything in the biotech world. Should PYMX go bankrupt, anyone interested in buying the assets would have to wait until the bankruptcy was completed. Who knows how long that would take. Also, I would imagine that the University of Penn would have some arrangement where the patents would revert back to them if this scenario were to occur. They could then license them to another more qualified company with deeper pockets.

Also.would the trials already conducted by PYMX even be admissible or would the new company have to start from scratch?

These are only a few reasons why I feel a buyout or cash infusion is more likely.

As Gandalf said....this is just my uninformed best guess.